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ABSTRACT 
Background: While there is suggestion that early onset of psychosis is a determinant of 
outcome, knowledge regarding correlates of later onset age is more limited. This study explores 
the characteristics of patients developing psychosis after age 26, towards the end of the usual 
age range of early intervention programs, in order to identify potential specific needs of such 
patients.  
Methods: 256 early psychosis patients aged 18-35 were followed-up prospectively over 36 
months. Patients with onset after 26 (“later onset”, LO) were compared to the rest of the sample.  
Results: LO patients (32% of the sample) had shorter DUP, were less likely to be male, had 
better premorbid functioning and were more likely to have been exposed to trauma. They had 
greater insight at presentation and less negative symptoms overall. The trajectories for positive 
and depressive symptoms were similar in both groups. Evolution of functional level was similar 
in both groups, but while LO patients recovered faster, they were significantly less likely to 
return to premorbid functional level. 
Conclusions: Later psychosis onset correlates with better pre-morbid functioning and higher 
rate of trauma exposure; the latter should therefore be a treatment focus in such patients. LO 
patients were less likely to return to premorbid functional level, which suggests that current 
treatment strategies may not be efficient to help patients maintain employment. The possibility 
of distinct illness mechanisms according to onset age and the more central role for trauma in 
patients with onset after age 26 needs to be further explored.  
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1. INTRODUCTION 
Textbooks usually list early age of onset (before age 18) as a rather robust predictor of poor 
outcome in schizophrenia. It is well documented that early onset schizophrenia is characterized 
by a progressive beginning rather than acute onset, associated with enduring negative 
symptoms followed by attenuated positive symptoms [1-3]. Some results in the literature are 
nevertheless inconsistent, available papers showing either a positive [4], a negative [5] or the 
absence of any effect [6, 7]. Age of onset is also correlated with different courses of cognitive 
deterioration [8, 9]. Most importantly, it has been shown that age at onset is a stronger 
determinant of neurocognition and social cognition levels than the age at the time of 
assessment [9, 10].  
Much fewer papers have explored the implications of late (onset after age 45) and very late 
(after 65) onset of schizophrenia, but available data suggest it may correlate with more positive 
symptoms and less negative symptoms [11, 12]. Although inconsistent, these elements strongly 
suggest that age at onset may determine specific needs and outcomes in psychosis patients.  
Early intervention programs, most commonly providing treatment to patients aged 18 to 35, aim 
at proposing interventions geared to specific patients’ needs. Based on our clinical observation, 
we realized that patients with a “later onset” (after age 26) often deal with specific challenges 
and displayed a different pattern of outcome than patients with earlier onset. Liu et al. [13] have 
found, through admixture analysis, that age 19 and 26 were relevant cut-off to identify clusters 
in early psychosis (EP) samples, and while most early psychosis programs in Australia do not 
include patients after age 26 [14], previous publications have shown that the proportion of 
patients with an onset after 26 is substantial [14, 15]. On this basis we explore in this paper 
premorbid, baseline and outcome characteristics of patients with psychosis onset after age 26 
(“later onset “, LO) and compare them to the other patients of our EP sample.  
 2. MATERIAL AND METHODS 
2.1 Procedure and participants 
Launched in 2004 at the Department of Psychiatry in Lausanne University Hospital, Switzerland, 
the Treatment and early Intervention in Psychosis Program (TIPP) is a specialized early 
psychosis program. Inclusion criteria are age between 18-35; living in catchment area 
(population about 300’000) and meeting criteria for psychosis, as defined by the ‘psychosis 
threshold’ subscale of the Comprehensive Assessment of At Risk Mental States (CAARMS) 
scale [16]. The program is a public integrated program which offers outpatient case 
management, assertive community treatment and an inpatient unit for a 36 months period. 
Patients can be addressed to TIPP from any psychiatric facility as soon as a diagnosis of 
psychosis is made and as long as patients have not had more than 6 months of previous 
treatment for psychosis. The program has been detailed elsewhere [17]. If patients have 
psychosis related to intoxication or organic brain disease, an intelligence quotient < 70 or have 
been taking antipsychotic medication for more than six months, patients are referred to other 
programs. This allows admission of patients who would have been treated unsuccessfully for a 
small amount of time, and we therefore refer to early psychosis (EP) rather than to first episode 
psychosis (FEP). Access to the TIPP clinical data was granted by the Ethics Committee of the 
Faculty of Biology and Medicine of Lausanne University, and consequently all patients who 
received treatment within this program were included in this study.  
 
2.2 Measures 
An ad hoc questionnaire was completed by the case managers (CM) who have up to a hundred 
contacts with patients during the 36 months of treatment. The case manager (CM) is a clinician 
(either a psychiatric nurse or a social assistant) who both coordinates and provides treatment 
and follow up to patient, along with a psychiatrist, over the entire 36 months treatment period; 
CMs are available for up to 2 home visits per week and on average patients have more than 
100 contacts with CM over the treatment period.[17, 18].The questionnaire allows the detailed 
evaluation of past medical history, demographic characteristics, exposure to adverse life events 
as well as symptoms and functioning. It is completed on the basis of information gathered from 
both patients and family during the beginning of treatment. Should new information emerge, it 
can be updated at any time during follow up. At baseline and after 2, 6, 12, 18, 24, 30 and 36 
months of treatment, a series of assessments focused on the evolution of symptoms and 
functional level are conducted by a psychologist and by case managers. This study is based on 
the prospective follow-up of the first 256 patients who were treated at TIPP. 
 
2.2.1 Diagnostic Assessment 
Expert consensus based diagnosis results from the following elements: Diagnosis reported by a 
treating psychiatrist (all medical documents including discharge documents after hospital 
admissions) and assessment by case managers over the 36 months of treatment. The 
consensus is carried out by a senior psychologist (CF) who is in charge of scale based 
assessment over the follow-up and a senior psychiatrist (LA). The entire file is reviewed after 18 
and 36 months, or at discharge. The diagnostic process is based on criteria from the DSM-IV 
[19]. In this paper, only the final diagnosis was used. 
 
2.2.2 Sociodemographic, clinical and functional data at baseline  
Duration of untreated psychosis (DUP) is defined as the time between onset of psychotic 
symptoms defined by CAARMS and admission to TIPP. Socio-economic status (SES) was 
subdivided into low, intermediate and high [20]. Functional characteristics at baseline were 
assessed according to both the Modified Vocational Status Index and the Modified Location 
Code Index Independent living [MVSI & MLCI; 21]. Migration in adversity was considered when 
migration occurred in adverse contexts such as: seeking protection for political reasons, threat 
of death, exposure to war or extreme poverty.  
Past psychiatric diagnoses were assessed according to DSM-IV criteria [19] while past suicide 
attempts were listed using ICD-10 classification [22]. Premorbid functional level was evaluated 
with the Premorbid Adjustment Scale [PAS; 23]. Academic and social sub-scores were 
computed as well as childhood and early adolescence sub-scores [24]. Past history of trauma 
was evaluated by case managers over the entire treatment phase and in the context of a 
trusting relationship [25, 26]. In this study patients were considered exposed to trauma if they 
had faced at least one experience of sexual or physical abuse prior the age of 16. Past 
diagnosis of substance abuse or dependence was rated according to DSM-IV criteria by case 
managers. 
The Global Assessment of Functioning [GAF; 19] and the Social and Occupational Functioning 
Assessment Scale [SOFAS; 19] were used in order to assess the functional level at baseline. 
While GAF also includes the intensity of symptoms, SOFAS only takes social and occupational 
level into account. The lowest SOFAS and GAF score before presentation was also estimated. 
Insight into illness was evaluated as complete, partial or absent on the basis of one item [27].  
 
2.2.3 Outcome measures after 2, 6, 12, 24, and 36 months of follow-up:  
Psychopathology and functional level were scored at each assessment, with SOFAS, GAF, the 
Positive and Negative Syndrome Scale [PANSS; 28] and the Montgomery-Asberg Depression 
Rating Scale [MADRS; 29]. A psychologist who was independent of patients’ treatment and had 
received standardized training prior to the study conducted the symptoms assessment. For the 
PANSS, Inter rater agreement standards [30] were confirmed through training with video-taped 
interviews and consensus reference ratings.  
 
2.2.4 Outcomes definitions at discharge 
Symptomatic remission at discharge was defined at the last PANSS assessment of the last year 
of the program following Andreasen’s Criteria [mild or lower (≤3) score on the following items: 
delusion, unusual thought content, hallucinatory behaviour, conceptual disorganization, 
mannerisms, blunted affect, social withdrawal & lack of spontaneity; 31]). Functional recovery 
was defined as a final PAS score equal or lower to the premorbid rating on four of the five PAS 
general scale’s items [32]. Items on education and abruptness in the change in work were 
ignored, considering they could not have changed during the period of interest [27]. Patients 
were considered as “living independently” on the basis of the MLCI (head of household / living 
alone, with partner, or with peers / living with family with minimal supervision). Patients were 
considered as “working” at discharge on the basis of the MVSI (paid or unpaid full- or part-time 
employment / being an active student in school or university / head of household with employed 
partner (homemaker) /full or part-time volunteer).  
 
2.3 Statistical analysis 
All comparisons were performed in the same metric with a series of logistic regression with age 
of onset (early/late) as the dependent variable, and the individual premorbid and service entry 
variables as predictors. Because gender and DUP differed in the baseline comparison, all 
further models were adjusted for these variables. In order to evaluate the impact of age of onset 
as a continuous variable, linear regressions, logistic regressions or general linear models were 
estimated with regards to the nature of each outcome (continuous & ordinal, dichotomous 
respectively nominal). These models were also adjusted for gender and DUP. Standardized , 
odd ratios (Exp()) and partial eta squares (p2) were reported together with indication of 
statistical significance. Mixed effects models repeated measures analysis of variance (MMRM) 
was used to determine group differences over time on the different measures. Time was 
introduced as a within-group factor and age of onset as a between-groups factor. From the 
model, the main effects for age of onset and time can be examined as well as their interaction. 
Being interested in contrasting change from first assessment to different endpoints and 
considering the numerous available measurements, planned comparisons within the MMRM 
were performed. It allowed us to test between group differences regarding rate of improvement 
in symptoms/functioning from first assessment to various endpoints. Gender and DUP were 
covariates. The selection of the optimal within-subject covariance matrix was determined with 
the AIC coefficient. Unstructured, autoregressive, compound-symmetric and Toeplitz structures 
were tested, including heterogeneous versions of these structures. Variants including age of 
onset as a continuous variable were also estimated. All statistical analyses were performed with 
IBM-SPSS 23. All statistical tests were two-tailed and significance was determined at the .05 
level.  
 
3. RESULTS 
3.1 Sociodemographic and clinical data according to age of onset 
LO patients had shorter duration of untreated psychosis (p=.004) and were less likely to be 
male (p=.002). They had higher level of education (p=.036) while having similar socio-economic 
level. They were more likely to be married (p<.001) or divorced (p=.046). LO patients were less 
likely to be students (p=.002) but unemployment rates were very similar in both groups. LO 
patients were more likely to live independently (p<.001) and they had a better premorbid 
functioning overall (p =.029) in all specific domains (childhood p=.030; early adolescence 
p=.012, social p=.010), except in academic achievement, were there was no group difference (p 
=.150). When treated as a continuous variable, later onset was also associated with better 
academic achievement (p =.002). While rates of past suicide attempt were similar between 
groups, later age of onset was associated with less past suicide attempt (p=.030) when this 
variable was treated as continuous. LO patients had higher rates of exposure to severe trauma 
(p=.034), and were more likely to be migrant in adversity (p =.004); they were however less 
likely to have lifetime alcohol abuse according to the DSM criteria (p =.002) and had greater 
insight at admission (p=.043). When treated as a continuous variable, age of onset had no 
significant effect on lifetime alcohol abuse. Functional level at baseline and diagnostic repartition 
were similar in both groups. 
Table 1 about here 
 
3.2 Clinical and functional outcome during the three years of follow up  
Disengagement rate was similar in both groups. Symptomatic and functional outcomes were 
similar as well, except that LO patients were less likely to return to premorbid level of functioning 
(p=.002).  
Table 2 about here 
Results of the longitudinal analyses revealed that both main effect of time (F6,194.721=5.516, 
p<.001) and age of onset (F1,194.280=4.071, p =.045) on the PANSS negative scores were 
significant. This indicated that patients’ negative symptomatology decreased during the program 
and that LO patients showed less severe negative symptoms overall (Figure 1a). However 
planned comparison did not reveal differences in rate of improvement between baseline and 
different endpoints. When age of onset was considered as a continuous variable, it was 
however not significantly related to negative symptomatology. The main effect of time on the 
PANSS positive scores was significant (F6, 219.865=4.006, p=.001) indicating that positive 
symptomatology of patients globally decreased over time regardless of onset age. The main 
effect of age of onset did not reveal significant differences between groups when all 
measurement occasions were taken into account. The trajectory of both groups across time was 
not affected by age of onset (see Figure 1b). The results were the same when age was taken as 
a continuous variable. Similarly, when MADRS scores were considered, trajectories of 
symptoms were similar in both groups and we only observed the main effect of time on 
symptoms levels (F6,225.656=10.338, p<.001). When age was considered as a continuous 
variable, results were similar.  
Figures 1a and 1b about here 
Regarding SOFAS scores, a main effect of time could be observed (F7,496.963=63.607, p<.001) 
indicating that patients increased their functioning during the program. While the main effect of 
age of onset proved to be not significant even when treated as a continuous variable, planned 
comparison contrasting change from baseline to 2 months indicated that LO patients 
experienced a faster recovery (t(1219.621)=2.728, p =.006). From month 6 to 36, both groups 
displayed similar functional levels. Regarding GAF scores, when functioning was based on 
GAF, there was a main effect for time (F7,551.916=56.945, p<.001) but no effect of age of onset 
even when treated as a continuous variable could be highlighted. The difference in rate of 
change over the first 2 months was not significant. 
Figures 2a and 2b about here 
4. DISCUSSION 
The purpose of this study was to explore the premorbid, baseline and outcome profile of EP 
patients with an onset after age 26, in order to see if there were suggestions for particular 
treatment needs in this patient group. In line with our hypothesis, LO patients displayed 
characteristics that may justify a specific therapeutic approach. 
One third of the sample had an onset after age 26, which is comparable to previous reports in 
similar programs [14, 15]. In line with other studies [33, 34], LO patients displayed a shorter 
DUP, which may be explained by a better social integration at the time of onset and hence a 
swifter reaction from close relatives or professional colleagues when symptoms became 
manifest. It could also be linked to a better knowledge of the health care system and a lower 
reluctance to get treatment than in younger patients. In addition, it is possible that once out of 
the adolescence phase, where psychotic symptoms are sometimes mistaken for more minor 
behavioural problems, psychotic symptoms emerging at a later age are less likely to be 
minimized. Finally, it is also possible that onset of psychosis is more progressive when it occurs 
earlier while it is more abrupt when occurring later in life.  
LO patients were significantly more likely to have been exposed to severe trauma or to have a 
history of migration in adversity. Greenfield et al. [15] highlighted that the majority of patients 
over 35 years had experienced trauma, but suggested this may have been linked to the higher 
proportion of female patients in their later onset subgroup, an observation confirmed in other 
studies [14, 35-38]. However, when adjusting all analysis for gender, the differences we 
observed remained significant, suggesting exposure to trauma is indeed an important 
characteristic of such patients. In line with others [39-42] we observed in a previous study that 
exposure to adverse experiences during childhood is associated with poorer functional [25] and 
symptomatic [26] recovery; the fact that LO patients were more likely to have been exposed to 
trauma may hence play a role in their failure to return to their pre-morbid functional level. 
Considering this, particular attention should be paid to the exploration of trauma history in LO 
patients in order to provide adequate support and psychological intervention. 
In addition, we observed that, despite better premorbid functional levels, LO patients had similar 
functional levels at baseline and at the end of the treatment phase when compared to patients 
with earlier onset. Although they improved faster on the basis of SOFAS scores, LO patients 
were also significantly less likely to return to premorbid functional levels. While this may seem 
somehow tautological considering LO patients had more to lose regarding functional levels than 
patients with an earlier onset as suggested by Riecher-Rössler et al. [43], this observation is 
nevertheless concerning. Indeed, it suggests that our specialized program fails to help patients 
maintain the competences they developed over the years before illness onset. Considering this, 
new strategies need to be implemented regarding vocational intervention as well as the socio-
political level, in order to better protect the professional status of patients when they develop 
psychosis [44]. 
In line with previous publications [11] there were no differences between both patients groups 
regarding symptomatic profile, except that LO patients displayed significantly less negative 
symptoms over the course of the program. This finding has to be tempered by the fact that the 
impact of age of onset as a continuous variable failled to reach statistical significance 
suggesting this finding is not very robust. Similarly we did not observe significant differences 
regarding diagnostic repartition according to age of onset. 
 
Taken together, all these elements suggest that age at the time of emergence of psychosis may 
be based on distinct illness mechanisms. Patients with earlier onset seem to display a more 
progressive illness process, starting in childhood as suggested by early disruption of premorbid 
adjustment, lower academic achievements and global lower premorbid level of functioning. This 
trajectory is more often complicated by substance abuse and outcome is relatively poor. On the 
other hand, LO patients seem to have displayed a good premorbid adjustment through the early 
phases of life, which allowed them to study, develop a career and social relationships. 
Considering the high rate of exposure to trauma in these patients, it could be suggested that the 
underlying illness mechanism is more likely to be driven by environmental factors with a more 
abrupt onset. This hypothesis is also supported by the observation that patients with a family 
history of schizophrenia have an earlier onset of illness [45-47]. However, while our data 
suggest that the age of onset may reflect differences in the underlying pathophysiology, more 
research is warranted to confirm this hypothesis. Indeed, different causal or risk factors could 
contribute with a differential weight, but also share many underlying mechanisms.  
This study has some limitations. First, while the sample is relatively large, the prevalence of the 
various characteristics we explored, such as trauma exposure, is small and our results should 
therefore be replicated in larger samples. Secondly, the age range of patients included in our 
sample is truncated and excludes patients younger than 18. This prevents the inclusion of 
patients with very young age at onset of the illness, which may greatly influence the results. 
However, considering the high number of early intervention programs applying this age range 
as inclusion criteria, our opinion is that the results of this study are useful considering they 
identify specific characteristics of LO patients and suggest they may deserve a specific 
approach. 
 
4.1 Conclusion 
Age at the onset of psychosis is the marker of distinct patient profiles. Patients with onset after 
26 years may need specific psychological intervention considering their higher likelihood to have 
been exposed to trauma. In addition, more effort should be made to protect their functional level 
and prevent their failure to return to the functional level they had attained before illness onset. 
The possibility of distinct illness mechanisms according to age of onset of psychosis needs to 
be explored considering it may pave the way to more specific and personalized interventions.   
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Table 1. Sociodemographic and clinical data according to age of of onset. 
 Total < 26 year ≥ 26 year Odd ratio 95% CI of OR p-
value 
Influence of 
age of onset 
as a 
continuous 
variable  
 N =256 N = 175 
(68.4%) 
N = 81 
(31.6%) 
 LCI UCI   
Age of onset in year, M 
(SD) 
23.14 
(5.21) 
20.27 
(3.30) 
29.35 
(2.40) 
- - - - - 
Age in year, M (SD) 24.56 
(4.833) 
21.97 
(3.041) 
30.16 
(2.817) 
2.680 2.01 3.571 <.001 =.882** 
Duration of untreated 
psychosis (days), Mdn 
(IQR)
a
 
90.50 
(480.25) 
127.00 
(584.00) 
55.0 
(141.00) 
0.634 0.464 0.866 .004 =-.281** 
Gender, male, % (N) 64.5 
(165) 
70.9 
(124) 
50.6 (41) 2.372 1.377 4.087 .002 Exp()=1.056* 
Socio-economical level, % 
(N) 
Low 
Intermediate 
High 
 
 
17.6 (45) 
44.9 
(115) 
37.5 (96) 
 
 
17.7 (31) 
44.0 (77) 
38.3 (67) 
 
 
17.3 (14) 
46.9 (38) 
35.8 (29) 
 
 
Ref.cat. 
1.199 
1.054 
 
 
- 
0.554 
0.476 
 
 
- 
2.592 
2.338 
 
 
- 
.645 
.896 
 
 
=.008 
Education in year, M (SD) 9.81 
(2.84) 
9.53 
(2.53) 
10.48 
(3.40) 
1.129 1.008 1.263 
 
.036 =.189** 
Marital status, % (N) 
Single 
Married 
Divorced 
Cohabitation 
 
82.8 
(207) 
9.2 (23) 
3.2 (8) 
4.8 (12) 
 
91.1 
(154) 
3.6 (6) 
1.8 (3) 
3.6 (6) 
 
65.4 (53) 
21.0 (17) 
6.2 (5) 
7.4 (6) 
 
Ref.cat. 
9.244 
4.793 
2.476 
 
- 
3.246 
1.025 
0.731 
 
- 
26.321 
22.421 
8.380 
 
- 
<.001 
.046 
.145 
 
p
2
=.162** 
Professional activity, % 
(N) 
Full time job 
Student/Traineeship 
Part time job 
Disability annuity 
On Sickness leave 
Unemployed 
 
 
13.2 (33) 
17.2 (43) 
2.4 (6) 
3.6 (9) 
18.0 (45) 
45.6 
(114) 
 
 
11.6 (20) 
22.7 (39) 
2.3 (4) 
2.3 (4) 
17.4 (30) 
43.6 (75) 
 
 
16.7 (13) 
5.1 (4) 
2.6 (2) 
6.4 (5) 
19.2 (15) 
50.0 (39) 
 
 
Ref.cat. 
0.136 
0.648 
2.827 
0.938 
0.999 
 
 
- 
0.037 
0.093 
0.550 
0.348 
0.427 
 
 
 
- 
0..495 
4.487 
14.542 
2.529 
2.341 
 
 
- 
.002 
.660 
.214 
.899 
.999 
 
 
p
2
=.136** 
Lifestyle, % (N) 
Family  
Independent household 
With friends 
Pension / care home 
Unsettled (hotel, shelter 
homeless) 
 
 
41.1 
(101) 
27.2 (67) 
22.0 (54) 
4.1 (10) 
5.7 (14) 
 
54.2 (91) 
14.9 (25) 
18.5 (31) 
4.8 (8) 
7.7 (13) 
 
12.8 (10) 
53.8 (42) 
29.5 (23) 
2.6 (2) 
1.3 (1) 
 
Ref.cat 
16.211 
7.146 
3.425 
1.104 
 
- 
6.874 
2.972 
0.602 
0.125 
 
- 
38.231 
17.181 
19.487 
9.775 
 
- 
<.001 
<.001 
.165 
.929 
 
p
2
=.334** 
Premorbid Adj. (PAS) M 
(SD) 
Childhood 
 
Early adolescence 
 
Social 
 
Academic 
 
Total 
 
0.30 
(0.19) 
0.32 
(0.17) 
0.29 
(0.21) 
0.35 
(0.20) 
0.31 
(0.17) 
 
0.32 
(0.20) 
0.34 
(0.18) 
0.32 
(0.22) 
0.37 
(0.20) 
0.33 
(0.18) 
 
0.25 
(0.16) 
0.27 
(0.13) 
0.23 
(0.18) 
0.31 
(0.18) 
0.26 
(0.14) 
 
0.132 
 
0.074 
 
0.104 
 
0.306 
 
0.089 
 
 
0.021 
 
0.010 
 
0.018 
 
0.061 
 
0.010 
 
 
0.818 
 
0.564 
 
0.583 
 
1.535 
 
0.776 
 
 
.030 
 
.012 
 
.010 
 
.150 
 
.029 
 
 
=-.201** 
 
=-.321** 
 
=-.267** 
 
=-.222** 
 
=-.286** 
Past suicide attempt, % 
(N) 
14.5 (35) 16.5 (27) 10.3 (8) 0.513 0.213 1.235 .136 Exp()=0.919* 
History of trauma
b
, % (N) 27.8 (71) 24.0 (42) 36.3 (29) 1.923 1.051 3.519 .034 Exp()=1.067* 
Migration in adversity, % 
(N) 
28.2 (72) 22.9 (40) 40.0 (32) 2.455 1.343 4.489 .004 Exp()=1.066* 
Born in Switzerland, % (N) 54.3 
(139) 
62.3 
(109) 
37.0 (30) 0.322 0.181 0.572 <.001 Exp()=0.905** 
Forensic history, % (N) 13.1 (29) 11.5 (18) 17.2 (11) 2.141 0.899 5.099 .085 Exp()=1.027 
         
Offences during program, 
% (N) 
12.0 (13) 15.5 (11) 5.4 (2) 0.387 0.078 1.906 .243 Exp()=0.921 
Psychiatric history, % (N) 62.3 
(157) 
65.9 
(114) 
54.4 (43) 0.627 0.350 1.121 .115 Exp()=0.978 
Familial psychiatric 
history, % (N) 
 
62.8 
(147) 
 
63.0 
(104) 
 
62.3 (43) 
 
1.066 
 
0.583 
 
1.950 
 
.836 
 
Exp()=1.001 
Familial schizophrenia 
history, % (N) 
 
24.1 (47) 
 
27.3 (36) 
 
17.5 (11) 
 
0.642 
 
0.296 
 
1.395 
 
.263 
 
Exp()=0.975 
Lifetime substance abuse 
(DSM), % (N) 
Alcohol 
Cannabis 
Other substances 
 
 
26.0 (63) 
39.7 (96) 
14.4 (36) 
 
 
33.5 (56) 
45.0 (76) 
15.2 (26) 
 
 
9.3 (7) 
27.4 (20) 
12.7 (10) 
 
 
0.251 
0.556 
0.941 
 
 
0.106 
0.296 
0.417 
 
 
0.595 
1.045 
2.122 
 
 
.002 
.068 
.883 
 
 
Exp()=0.941 
Exp()=0.946 
Exp()=1.012 
Lifetime substance 
addiction (DSM), % (N) 
Alcohol 
Cannabis 
Other substances 
 
 
9.9 (24) 
31.8 (77) 
7.2 (18) 
 
 
11.3 (19) 
36.7 (62) 
8.2 (14) 
 
 
6.7 (5) 
20.5 (15) 
5.1 (4) 
 
 
0.740 
0.554 
0.620 
 
 
0.254 
0.281 
0.190 
 
 
2.155 
1.093 
2.019 
 
 
.581 
.089 
.427 
 
 
Exp()=1.023 
Exp()=0.958 
Exp()=1.002 
Insight at presentation, % 
(N) 
Absent 
Partial 
Complete 
 
 
36.7 (90) 
45.7 
(112) 
17.6 (43) 
 
 
38.3 (64) 
47.9 (80) 
13.8 (23) 
 
 
33.3 (26) 
41.0 (32) 
25.6 (20) 
 
 
Ref. cat. 
1.020 
2.241 
 
 
- 
0.539 
1.024 
 
 
- 
1.930 
4.903 
 
 
- 
.952 
.043 
 
 
=.096 
GAF, M (SD) 
Baseline 
 
Worst during psychosis 
 
36.93 
(16.29) 
25.40 
(10.96) 
 
36.40 
(16.03) 
25.39 
(10.74) 
 
38.05 
(16.91) 
25.41 
(11.47) 
 
1.003 
 
0.999 
 
0.986 
 
0.973 
 
1.021 
 
1.025 
 
.700 
 
.913 
 
=.051 
 
=.009 
SOFAS, M (SD) 
Baseline 
 
Worst during psychosis 
 
39.03 
(15.61) 
28.43 
(11.97) 
 
38.92 
(15.119) 
28.69 
(11.78) 
 
 
39.25 
(16.69) 
27.92 
(12.40) 
 
1.001 
 
0.997 
 
0.984 
 
0.973 
 
1.019 
 
1.021 
 
.911 
 
.798 
 
=.037 
 
=.017 
CGI, M (SD) 
Baseline 
 
Higher during psychosis 
 
4.91 
(1.36) 
5.87 
(0.76) 
 
4.98 
(1.31) 
5.89 
(0.77) 
 
4.77 
(1.46) 
5.83 
(0.74) 
 
0.875 
 
0.825 
 
0.706 
 
0.556 
 
1.084 
 
1.224 
 
.222 
 
.340 
 
=-.104 
 
=-.077 
Diagnostic, % (N) 
Schizophrenia 
 
Schizophreniform/brief 
Schizo-affective 
Major depression
c
 
Bipolar disorder 
Other  
 
59.4 
(152) 
10.2 (26) 
9.8 (25) 
2.3 (6) 
8.2 (21) 
10.2 (26) 
 
63.4 
(111) 
9.7 (17) 
7.4 (13) 
1.7 (3) 
7.4 (13) 
10.3 (18) 
 
50.6 (41) 
 
11.1 (9) 
14.8 (12) 
3.7 (3) 
9.9 (8) 
9.9 (8) 
 
Ref. cat. 
 
0.938 
1.790 
1.982 
1.233 
0.924 
 
- 
 
0.368 
0.725 
0.368 
0.458 
0.358 
 
- 
 
2.391 
4.424 
10.682 
3.320 
2.380 
 
- 
 
.893 
.207 
.426 
.679 
.869 
p
2
=.005 
Note. Mdn = Median. IQR = Interquartile range. Ref.cat = reference category. a = Raw data are presented, however 
the test statistics were based on log10 (+constant) transformed data because of extreme positive skewness; 
b
 
physical or sexual abuse 
c
 with psychotic features. All model were adjusted for gender and duration of untreated 
psychosis. * p<.05, ** p<.01. 
  
Table 2. Outcomes according to age of of onset. 
 Total < 26 year ≥ 26 year Odd ratio 95% CI of OR p-
value 
Influence of 
age of onset 
as a 
continuous 
variable 
 N =256 N = 175 
(68.4%) 
N = 81 
(31.6%) 
 LCI UCI   
Program commitment, % 
(N) 
Seen at least once 
Interruption > 2 months 
Lost from sight 
 
 
97.8 
(181) 
23.5 (12) 
12.9 (23) 
 
 
97.7 (127) 
23.4 (30) 
12.6 (16) 
 
 
98.2 (54) 
23.5 (12) 
13.7 (7) 
 
 
2.033 
1.048 
1.138 
 
 
0.193 
0.479 
0.429 
 
 
21.385 
2.293 
3.019 
 
 
.555 
.907 
.796 
 
 
Exp()=0.938 
Exp()=1.033 
Exp()=1.031 
Follow-up after program, 
% (N) 
Specialized ambulatory 
care 
Other ambulatory care 
Private practice 
psychiatrist/psychologist 
General practitioner 
No follow-up needed 
Other 
 
 
51.1 (90) 
 
12.5 (22) 
 
21.6 (38) 
5.7 (10) 
3.4 (6) 
5.7 (10) 
 
 
54.0 (68) 
 
11.9 (15) 
 
19.8 (25) 
7.1 (9) 
2.4 (3) 
4.8 (6) 
 
 
44.0 (22) 
 
14.0 (7) 
 
26.0 (13) 
2.0 (1) 
6.0 (3) 
8.0 (4) 
 
 
Ref. cat. 
 
1.423 
 
1.220 
0.252 
2.459 
1.833 
 
 
- 
 
0.502 
 
0.511 
0.029 
0.423 
0.452 
 
 
- 
 
4.035 
 
2.912 
2.164 
14.313 
7.423 
 
 
- 
 
.507 
 
.654 
.209 
.317 
.396 
 
 
p
2
=.029 
Symptomatic response at 
the last assessment of the 
last year of the program 
(Andreassen), % (N) 
 
 
 
50.7 (75) 
 
 
 
47.1 (49) 
 
 
 
59.1 (26) 
 
 
 
1.208 
 
 
 
0.545 
 
 
 
2.674 
 
 
 
.642 
 
 
 
Exp()=0.999 
Functional recovery (PAS) 
at the last assessment of 
the last year of the 
program, % (N) 
 
 
 
44.8 (73) 
 
 
 
51.8 (59) 
 
 
 
28.6 (14) 
 
 
 
0.289 
 
 
 
0.133 
 
 
 
0.630 
 
 
 
.002 
 
 
 
Exp()=0.905** 
Functional recovery – 
independent work, % (N) 
 
24.2 (47) 
 
22.6 (31) 
 
28.1 (16) 
 
1.103 
 
0.532 
 
2.288 
 
.792 
 
Exp()=1.014 
Functional recovery – 
independent living, % (N) 
 
56.7 
(110) 
 
52.6 (72) 
 
66.7 (38) 
 
1.584 
 
0.817 
 
3.070 
 
.174 
 
Exp()=1.069* 
Combined functional 
recovery (indep. work & 
living), % (N) 
 
 
20.6 (40) 
 
 
19.0 (26) 
 
 
24.6 (14) 
 
 
1.135 
 
 
0.526 
 
 
2.449 
 
 
.746 
 
 
Exp()=1.023 
Note. Ref.cat = reference category. All model were adjusted for gender and duration of untreated psychosis. * p<.05, 
** p<.01. 
  
Figure 1. PANSS scores over 36 months: Comparisons between early and late onset patients. 
 
  
1a) PANSS negative score 1b) PANSS positive score
Abbreviations: PANSS = Positive and Negative Syndrome Scale
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Figure 2. Functioning scores over 36 months: Comparisons between early and late onset 
patients. 
 
 
 
2a) SOFAS scores 2b) GAF scores
Abbreviations: SOFAS = Social and Occupational Functioning Assessment Scale , GAF = Global Assessment of Functioning
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